Synthesis and modulation of cytokine production by two new adamantane substituted acyclic desmuramyldipeptide analogs

Citation
S. Gobec et al., Synthesis and modulation of cytokine production by two new adamantane substituted acyclic desmuramyldipeptide analogs, PHARMAZIE, 56(7), 2001, pp. 523-526
Citations number
17
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMAZIE
ISSN journal
00317144 → ACNP
Volume
56
Issue
7
Year of publication
2001
Pages
523 - 526
Database
ISI
SICI code
0031-7144(200107)56:7<523:SAMOCP>2.0.ZU;2-A
Abstract
Two new adamantyl-desmuramyldipeptides LK 415 and LK 517 with 1-adamantylca rboxamido moiety as a replacement for muramyldipeptide's N-acetylglucosamin e fragment were synthesized. Their efficacy to modulate the production of c ytokines was measured in vitro in ionomycin and phorbol-12-myristate-13-ace tate (PMA) activated cultures of human peripheral blood mononuclear cells ( PBMC), co-incubated with the substances tested. The results were compared w ith the activity of muramyldipeptide (MDP). All three substances are strong up-regulators of IL-12 synthesis and hence of the IFN gamma synthesis as w ell. While MDP and LK 415 are relatively ineffective in modulation of IL-2, IL-4 and IL-10 production in vitro, the synthesis of all three cytokines i s cosiderably up-regulated when peripheral blood mononuclear cells are co-i ncubated with LK 517. It seems likely that the introduction of the diethyl phosphonate moiety into LK 517 is of great importance for the augmented T-c ell cytokine production.